Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares went up after the company has raised its cash portion of its offer for Allergan Inc .That J. Michael Pearson, Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s chief executive, commented in a letter to Allergan’s chairman and CEO David Pyott that his firm has listened to the views of a lot of Allergan shareholders and planned to boost the offer. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) net profit margin is -13.10% and weekly performance is -3.07%. On last trading day company shares ended up $126.95. Analysts mean target price for the company is $52.38. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) distance from 50-day simple moving average (SMA50) is -2.61%.
On 27 MAY Alkermes Plc (NASDAQ:ALKS) reported $0.11 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.10 by $0.01. The company had revenue of $130.21 million for the quarter, compared to the consensus estimate of $135.79 million. During the same quarter in the prior year, the company posted $0.40 earnings per share. The company’s quarterly revenue was down 20.3% on a year-over-year basis. Analysts expect that Alkermes Plc will post $0.49 EPS for the current fiscal year. Alkermes Plc (NASDAQ:ALKS) shares fell -2.16% in last trading session and ended the day on $45.74. ALKS Gross Margin is 69.40% and its return on assets is 1.40%. Alkermes Plc (NASDAQ:ALKS) quarterly performance is -13.22%.
On 27 MAY Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) announced in a press release that it has entered into a Settlement Agreement with Sandoz Inc. to settle Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) ‘s patent infringement action pending against Sandoz in the United States District Court for the District of Delaware. Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) shares moved down -11.11% in last trading session and was closed at $1.12, while trading in range of $1.00 – $1.12. Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) year to date (YTD) performance is -32.93%.
On 7 MAY Delcath Systems, Inc. (NASDAQ:DCTH) reported first quarter ended March 31, 2014. For the first quarter ended March 31, 2014, total product revenue was $0.3 million compared with total product revenue of approximately $0.1 million in the first quarter 2013. Operating expenses decreased by approximately 50% to $5.3 million from $10.6 million for the same period in 2013.
Delcath Systems, Inc. (NASDAQ:DCTH) ended the last trading day at $2.79. Company weekly volatility is calculated as 6.93% and price to cash ratio as 0.84. Delcath Systems, Inc. (NASDAQ:DCTH) showed a positive weekly performance of 8.98%.
On 5 MAY Petmed Express Inc (NASDAQ:PETS) reported Q4 EPS of $0.23, $0.01 better than the analyst estimate of $0.22. Revenue for the quarter came in at $48.6 million versus the consensus estimate of $55.02 million. Petmed Express Inc (NASDAQ:PETS) net profit margin is 9.70% and weekly performance is 1.05%. On last trading day company shares ended up $13.44. Analysts mean target price for the company is $14.00. Petmed Express Inc (NASDAQ:PETS) distance from 50-day simple moving average (SMA50) is 3.59%.